Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma

Gastroenterology

Volumn 121, Issue 4, 2001, Pages 823-829

  Machado, José Carlos ^a,b   Pharoah, Paul ^a,c   Sousa, Sónia ^a   Carvalho, Ralph ^a   Oliveira, Carla ^a,c   Figueiredo, Céu ^a   Amorim, António ^a,d   Seruca, Raquel ^a   Caldas, Carlos ^a,c   Carneiro, Fátima ^a,e   Sobrinho Simões, Manuel ^a,e  

^a Institute of Molecular Pathology and Immunology of the University of Porto ^*

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d Chemistry Investigation Centre (CIQ)   (Portugal)

^e HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 1RN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0034793044     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.28000     Document Type: Article

References (27)

1. Hypothesis: The changing relationships of Helicobacter pylori and humans: Implications for health and disease
2. Helicobacter pylori infection and the risk of gastric carcinoma
3. Gastric cancer: A long-term consequence of Helicobacter pylori infection?
4. Helicobacter pylori and gastric diseases
5. Pathophysiology of Helicobacter pylori infection
6. Bacterial factors and immune pathogenesis in Helicobacter pylori infection
7. Human gastric carcinogenesis: A multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention
8. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement
9. New elements for an updated classification of the carcinomas of the stomach
10. Biologic basis for interleukin-1 in disease
11. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection
12. Helicobacter pylori infection enhances mucosal interleukin-1 beta, interleukin-6, and the soluble receptor of interleukin-2
13. Interleukin-1 receptor antagonist: Role in biology
14. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
15. A Taql polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro
16. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes
17. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro
18. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases
19. Cytokine production by normal human monocytes: Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism
20. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification
21. Gastric carcinoma exhibits distinct types of cell differentiation: An immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC and MUC6)
22. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat
23. Estimates of the worldwide frequency of sixteen major cancers in 1980
24. Helicobacter pylori: The Portuguese scene
25. Characteristics of the gastric mucosa of direct relatives of patients with sporadic gastric carcinoma
26. The extent of linkage disequilibrium in four populations with distinct demographic histories
27. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes